» Articles » PMID: 28167557

Enterocin AS-48 As Evidence for the Use of Bacteriocins As New Leishmanicidal Agents

Overview
Specialty Pharmacology
Date 2017 Feb 8
PMID 28167557
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

We report the feasibility of enterocin AS-48, a circular cationic peptide produced by , as a new leishmanicidal agent. AS-48 is lethal to promastigotes as well as to axenic and intracellular amastigotes at low micromolar concentrations, with scarce cytotoxicity to macrophages. AS-48 induced a fast bioenergetic collapse of promastigotes but only a partial permeation of their plasma membrane with limited entrance of vital dyes, even at concentrations beyond its full lethality. Fluoresceinated AS-48 was visualized inside parasites by confocal microscopy and seen to cause mitochondrial depolarization and reactive oxygen species production. Altogether, AS-48 appeared to have a mixed leishmanicidal mechanism that includes both plasma membrane permeabilization and additional intracellular targets, with mitochondrial dysfunctionality being of special relevance. This complex leishmanicidal mechanism of AS-48 persisted even for the killing of intracellular amastigotes, as evidenced by transmission electron microscopy. We demonstrated the potentiality of AS-48 as a new and safe leishmanicidal agent, expanding the growing repertoire of eukaryotic targets for bacteriocins, and our results provide a proof of mechanism for the search of new leishmanicidal bacteriocins, whose diversity constitutes an almost endless source for new structures at moderate production cost and whose safe use on food preservation is well established.

Citing Articles

Antiparasitic Activity of Enterocin M and Durancin-like from Beneficial in Mice Experimentally Infected with .

Petrova M, Hurnikova Z, Laukova A, Dvoroznakova E Microorganisms. 2024; 12(5).

PMID: 38792753 PMC: 11123709. DOI: 10.3390/microorganisms12050923.


The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story.

Skoufou M, Tsigalou C, Vradelis S, Bezirtzoglou E Microorganisms. 2024; 12(1).

PMID: 38258020 PMC: 10818559. DOI: 10.3390/microorganisms12010194.


Modulatory Effect of Beneficial Enterococci and Their Enterocins on the Blood Phagocytes in Murine Experimental Trichinellosis.

Vargova M, Revajova V, Laukova A, Hurnikova Z, Dvoroznakova E Life (Basel). 2023; 13(9).

PMID: 37763333 PMC: 10532878. DOI: 10.3390/life13091930.


Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease.

Robledo S, Perez-Silanes S, Fernandez-Rubio C, Poveda A, Monzote L, Gonzalez V Pathogens. 2023; 12(7).

PMID: 37513786 PMC: 10383258. DOI: 10.3390/pathogens12070939.


A Review on Enterocin DD14, the Leaderless Two-Peptide Bacteriocin with Multiple Biological Functions and Unusual Transport Pathway.

Ladjouzi R, Dussert E, Teiar R, Belguesmia Y, Drider D Antibiotics (Basel). 2023; 12(7).

PMID: 37508284 PMC: 10376788. DOI: 10.3390/antibiotics12071188.


References
1.
Cornut G, Fortin C, Soulieres D . Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol. 2008; 31(4):399-404. DOI: 10.1097/COC.0b013e31815e456d. View

2.
Porrini M, Audisio M, Sabate D, Ibarguren C, Medici S, Sarlo E . Effect of bacterial metabolites on microsporidian Nosema ceranae and on its host Apis mellifera. Parasitol Res. 2010; 107(2):381-8. DOI: 10.1007/s00436-010-1875-1. View

3.
Galvez A, Maqueda M, Martinez-Bueno M, Valdivia E . Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J Bacteriol. 1991; 173(2):886-92. PMC: 207084. DOI: 10.1128/jb.173.2.886-892.1991. View

4.
Sosunov V, Mischenko V, Eruslanov B, Svetoch E, Shakina Y, Stern N . Antimycobacterial activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother. 2007; 59(5):919-25. DOI: 10.1093/jac/dkm053. View

5.
Maqueda M, Galvez A, Martinez-Bueno M, Guerra I, Valdivia E . Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies. Antimicrob Agents Chemother. 1993; 37(1):148-51. PMC: 187625. DOI: 10.1128/AAC.37.1.148. View